Myricetin ameliorates letrozole-induced PCOS in female rats-a mechanistic approach through in silico, in vitro, and in vivo study via P13/AKT and NF-κB pathway crosstalk
Abstract
Polycystic ovarian syndrome (PCOS) is one of the leading causes of abnormalities in young female patients. Myricetin is flavonoid which has multiple pharmacological effects like anti-inflammatory, antidiabetic, and anticancer. This study determined the effect of myricetin in the treatment of PCOS. For in silico studies, network pharmacology and molecular docking and simulation were done through multiple software tools. In vitro evaluation was done through antioxidant assays (DPPH and ABTS). Female Sprague Dawley rats were used in six groups. Letrozole (1 mg/kg) in 0.5% CMC was used to induce PCOS for 21 days, while CMC was the only treatment given to the normal control. Metformin (20 mg/kg) or myricetin (75, 150, and 300 mg/kg) was administered for 15 days. On day 37, ovarian tissues were homogenized for antioxidant tests and RT-qPCR gene expression analysis, reproductive organs were gathered for histology, and blood was processed for ELISA and LFTs. Network pharmacology shows significant effects of myricetin within the body; however, molecular docking and simulation studies show that Protein kinase B (AKT) has a greater binding capacity with myricetin. It also shows maximum antioxidant activity through antioxidant assays. Myricetin's safety was validated by biochemical, oxidative stress, and histopathological analyses. It enhanced follicular structures and significantly reduced body weight and ovarian cysts. By lowering testosterone (0.265 ± 0.021 mIU/mL vs. 0.735 ± 0.14),…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.